Home/Pipeline/Desmopressin (Nocutil)

Desmopressin (Nocutil)

Nocturnal Enuresis, Diabetes Insipidus

ApprovedActive

Key Facts

Indication
Nocturnal Enuresis, Diabetes Insipidus
Phase
Approved
Status
Active
Company

About Gebro Pharma

Gebro Pharma is a century-old, privately held Austrian pharmaceutical company with a strong emphasis on maintaining its independence and family ownership. Its core business is the development, licensing, and global commercialization of a portfolio of small molecule therapeutics, many of which are already approved and marketed. The company leverages a decentralized operational structure with key subsidiaries in Europe to manage risks and drive international growth, particularly in Latin America and other emerging markets.

View full company profile